The Children’s Tumor Foundation has launched its latest cycle of neurofibromatosis (NF)-noncancerous tumor–research and clinical funding initiatives.
This global call aims to attract top-tier scientific talent to address the urgent need for effective treatments for NF1, NF2-related schwannomatosis, and non-NF2 schwannomatosis.
By prioritizing innovative science, the foundation seeks to transform the landscape of NF care from the lab bench to the patient’s bedside.
These grants serve as a catalyst for high-impact discoveries that can improve the lives of millions worldwide who are affected by these conditions.
Funding and benefits
The initiative offers substantial financial support, including salary for pre- and post-doctoral fellows and project-specific funding for established investigators.
Funding of up to two years with a total budget of $200,000 is available.
Beyond direct funding, recipients gain access to a robust research ecosystem, including the NF Data Portal and the annual NF Conference.
This integration allows for unprecedented data sharing and networking with the world’s leading experts in the field.
Successful applicants will also benefit from the foundation’s commitment to professional development.
This support ensures that early-career scientists are equipped with the resources and visibility necessary to become the next generation of NF research leaders.
Eligibility
Eligibility is open to a wide range of researchers, from graduate students and post-doctoral fellows to senior scientists leading complex clinical trials.
Applicants must be affiliated with an accredited academic or medical institution.
Projects must focus specifically on neurofibromatosis or related schwannomatosis conditions to qualify for support.
The foundation encourages diverse perspectives and interdisciplinary approaches to solve the most pressing challenges in NF biology and clinical care.
Application requirement
Prospective candidates are required to submit their proposals through the foundation’s official electronic application portal.
The process typically begins with a Letter of Intent (LOI), which is then peer-reviewed to determine if a full proposal will be invited.
Applications must include a detailed project plan, budget justification, and a description of how the work aligns with the foundation’s strategic goals.
Applicants must hold an MD, PhD, or an equivalent degree from a recognized institution and must have full access to, or identified collaborators with, all required in vivo and in vitro resources.
Precision in scientific methodology and clear clinical relevance are essential criteria for the selection committee.
Deadline
The deadline for this application is February 02, 2026. Visit Children’s Tumor Foundation website to apply . Explore more global calls on our Opportunities page
Summary not available at this time.
